Wait what? Did you look at the timeline? I'll add it again with an arrow to show where we are. As you can see, as recently as November, they believed(?) that they would have completed and released trial results for a phase 1/2 UTI trial AND a phase 2 sepsis trial. They also believed(?) that they would be starting a phase 3 UTI AND a phase 3 sepsis trial before the end of this year!
Instead, they only completed a phase 1 "UTI" trial (more correctly, rapid IV trial). No phase 2 sepsis trial ever referred to again. And the phase 2 UTI trial only due to start H2 this year, instead of a phase 3.
Not to mention the compete miss on the topical 327 timelines.
This ridiculous timeline was pointed out in November. If it is clear to investors that it was ridiculous, then whoever made this timeline is either an imbecile or deliberately misleading.
(20min delay)